# ACTINOBAC BIOMED, INC. — Form D

ACTINOBAC BIOMED, INC. of KENDALL PARK, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2017-07-24. The offering totals $2.4M, of which $2.4M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2017-07-24
- Form: D
- Accession: 0001712650-17-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.4M
- Amount sold: $2.4M
- Investors: 1
- Date of first sale: 2017-07-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-291365

## Issuer

- Name: ACTINOBAC BIOMED, INC.
- CIK: 0001712650
- Entity type: Corporation
- Jurisdiction: NEW JERSEY
- Address: 15 PELHAM RD, KENDALL PARK, NJ, 08824
- Phone: 732-371-2694

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| BENJAMIN BELINKA | Director | KENDALL PARK, NJ |
| BENJAMIN BELINKA | Executive Officer | KENDALL PARK, NJ |
| Scott Kachlany | Director | Kendall Park, NJ |
| Peter Alff | Director | Kendall Park, NJ |
| James Golubieski | Director | Kendall Park, NJ |
| Benjamin Belinka, Jr. | Director | Kendall Park, NJ |
| Benjamin Belinka, Jr. | Executive Officer | Kendall Park, NJ |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2018-06-08](https://search.stillhousedata.com/formd/0001712650-18-000001) | D | $6.0M | $1.0M |

## More

- [CIK 1712650 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1712650&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001712650-17-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.